Cardlytics, Inc.

For the period ended Jun 30, 2025. Filed Aug 6, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 6, 2025

CDLX$1.63-10.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations (Unaudited)

(Amounts in thousands, except per share amounts)

	Three Months EndedJune 30,		Six Months EndedJune 30,
	2025	2024	2025	2024
Revenue	$63,249	$69,636	$125,147	$137,244
Costs and expenses:
Partner Share and other third-party costs	27,103	33,258	56,553	63,801
Delivery costs	6,883	7,661	14,171	13,834
Sales and marketing expense	11,335	14,025	24,089	28,143
Research and development expense	11,295	13,470	23,001	26,518
General and administrative expense	12,905	16,151	26,683	30,636
Acquisition, integration and divestiture costs	—	162	—	162
Change in contingent consideration	42	(5,808)	102	9
Loss (gain) on disposal or divestiture	200	—	(5,150)	—
Depreciation and amortization expense	6,275	6,529	12,566	12,779
Total costs and expenses	76,038	85,448	152,015	175,882
Operating Loss	(12,789)	(15,812)	(26,868)	(38,638)
Other income (expense):
Interest expense, net	(1,943)	(1,561)	(3,773)	(2,380)
Foreign currency gain (loss)	5,449	99	8,076	(531)
Gain on debt extinguishment	—	13,017	—	13,017
Total other income	3,506	11,555	4,303	10,106
Loss before income taxes	(9,283)	(4,257)	(22,565)	(28,532)
Net Loss	$(9,283)	$(4,257)	$(22,565)	$(28,532)
Net Loss per share, basic and diluted	$(0.18)	$(0.09)	$(0.43)	$(0.62)
Weighted-average common shares outstanding, basic and diluted	52,750	49,056	52,309	46,168

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.